ICONOVO HAS A NEW GRANTED PATENT
The Swedish Patent and Registration Office, PRV, has granted a new patent for ICOres. SE 539 930 C2. Another milestone for this inventive inhaler.
New employees at Iconovo
We welcome our two new associates; Eva Persson and Mea Lindsjö. Eva works with Pharmaceutical Development and Mea is our new Executive Assistant.
Iconovo at FDA workshop
Iconovo CEO Dr. Orest Lastow took part in an FDA workshop on the evaluation of new methods for characterizing and demonstrating equivalence of OINDP. The…
Swedish Iconovo signs royalty-backed inhalation contract worth 2.8 million EUR
Iconovo, a Swedish inhalation development company has signed a second major product development and licensing agreement with Intas Pharmaceuticals Ltd.…
Iconovo News 2017
Iconovo has had a fantastic year. In May, we raised 2.5 million EUR to invest in our formulation development capability. As a consequence we have moved…
DDL
Iconovo is proud to sponsor DDL this year again. We see DDL as the most important meeting for inhaled drug delivery in Europe and we are looking forward…
Iconovo has a new granted patent
The Swedish Patent and Registration Office, PRV, has granted Iconovo's first ICOone patent. This is a key milestone showing that Iconovo's inhalers are…
New employees at Iconovo
We welcome our two new associates; Maggie Adméus and Henrik Svedberg. Maggie as an Executive Assistant and Henrik as a Mechanical Engineer.
New employee at Iconovo
Mårten Appelgren has joined Iconovo as Director Business Development. Mårten has over 25 years experience from the inhalation industry. Mårten has previously…
New employee at Iconovo
We are very glad to announce that Vesna Åkerberg has joined Iconovo as Director of Pharmaceutical Development. Vesna will head the new dry powder formulation…
